Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
‘No one is ever really ready’: Aid-in-dying patient chooses his last day

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

Scientists discover key vulnerability of mixed lineage leukemia

Scientists discover key vulnerability of mixed lineage leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

New discovery could pave way for improved leukemia treatment

New discovery could pave way for improved leukemia treatment

Combination of arsenic and existing leukemia drug may combat cancer

Combination of arsenic and existing leukemia drug may combat cancer

New CAR T-cell immunotherapy trial targets solid tumors

New CAR T-cell immunotherapy trial targets solid tumors

Engineers create next-generation wristbands to monitor health, environmental exposures

Engineers create next-generation wristbands to monitor health, environmental exposures

Research uncovers new approach for expanding stem cells from umbilical cord blood

Research uncovers new approach for expanding stem cells from umbilical cord blood

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

New AI approach can teach itself to design new drug molecules from scratch

New AI approach can teach itself to design new drug molecules from scratch

Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

Scientists find people's assumptions about DNA repair after CRISPR editing to be wrong

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Portfolio diet reduces risk factors for cardiovascular disease

Portfolio diet reduces risk factors for cardiovascular disease

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation